MetaADEDB 2.0 @ LMMD
Bacitracin zinc and polymyxin B sulfate
(JAHOMMMKSLNARO-BVTVREHZSA-N)
Structure
SMILES
OS(=O)(=O)O.NCCC(C(=O)NC1CCNC(=O)C(CCO)NC(=O)C(CCN)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)Cc1ccccc1)CC(C)C)CCN)NC(=O)C(NC(=O)C(NC=O)CCN)CCO.CCN[C@H](C(=O)CC(=O)[C@H](Cc1[nH]cnc1)NCN[C@H](C(=O)CCC(=O)[C@H]([C@@H](CC)C)NCCC(=O)C1CSC(=N1)C(C(CC)C)N)[C@@H](CC)C)CC(=O)N.[Zn]
Molecular Formula:
C87H151N25O23S2Zn
Molecular Weight:
2044.790
Log P:
4.6328
Hydrogen Bond Acceptor:
48
Hydrogen Bond Donor:
27
TPSA:
842.56
CAS Number(s):
N/A
Synonym(s)
1.
Bacitracin zinc and polymyxin B sulfate
External Link(s)
PubChem Compound24848131
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 2US FAERS
2HypersensitivityFAERS: 2US FAERS
3UrticariaFAERS: 2US FAERS
4DiscomfortFAERS: 1US FAERS
5ErythemaFAERS: 1US FAERS
6Eye irritationFAERS: 1US FAERS
7Incision site complicationFAERS: 1US FAERS
8Incision site painFAERS: 1US FAERS
9Incorrect drug administration durationFAERS: 1US FAERS
10Product quality issueFAERS: 1US FAERS
11PruritusFAERS: 1US FAERS
12Rash erythematousFAERS: 1US FAERS
13SwellingFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120263

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.